Q: How does olezarsen work?

Mechanism of Action Olezarsen is a type of medication known as an antisense oligonucleotide. It works by targeting and blocking the genetic instructions (mRNA) that the body uses to produce a protein called apolipoprotein C-III (apoC-III). Role of apoC-III The apoC-III protein is primarily made in the liver and plays a key role in regulating fat levels in the blood. Under normal conditions, this protein inhibits the enzymes responsible for breaking down triglycerides and prevents the liver from clearing certain fat particles from the bloodstream. How Olezarsen Lowers Triglycerides By reducing the amount of apoC-III protein available, olezarsen helps the body manage fats more effectively. This results in: Increased fat breakdown: Lower levels of apoC-III allow enzymes to more efficiently break down triglycerides. Improved clearance: The body can more easily remove triglyceride-rich particles from the blood. This mechanism helps significantly lower triglyceride levels in adults with familial chylomicronemia syndrome (FCS), a condition where the body cannot properly break down fats.

Q: What are the active ingredients in olezarsen?

The active ingredient in olezarsen is olezarsen .

Q: What are the side effects of olezarsen?

Common side effects of olezarsen may include: injection site reactions fatigue headache Always consult with a healthcare professional about potential side effects.

Q: What drug class is olezarsen?

olezarsen belongs to the antisense oligonucleotide drug class.

Q: What is the dosage of olezarsen and how do I take it?

How to Use Olezarsen is administered as an injection under the skin (subcutaneously). It is typically used once monthly. A healthcare provider will provide instructions on how to properly inject the medication if you or a caregiver will be performing the injections at home. Administration and Sites The injection can be given in the abdomen, the front of the thighs, or the outer area of the upper arms. It is important to rotate the injection site each time you use the medication. Avoid injecting into areas where the skin is tender, bruised, red, or scarred. Preparation The medication should be taken out of the refrigerator and allowed to reach room temperature before use. Do not shake the syringe. Before injecting, check the liquid to ensure it is clear and colorless to slightly yellow. If the liquid is cloudy or contains visible particles, do not use it. Missed Dose If you miss a dose, take it as soon as possible. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not use extra medication to make up for a missed dose.

Q: Is olezarsen safe during pregnancy and breastfeeding?

Pregnancy There are no adequate or well-controlled studies on the use of olezarsen in pregnant women. While animal studies did not show evidence of harm to the fetus at doses significantly higher than the recommended human dose, it is not known if the drug will cause harm to a human pregnancy. If you are pregnant or planning to become pregnant, talk to your healthcare provider about the potential risks and benefits of continuing or starting this medication. Breastfeeding It is currently unknown if olezarsen passes into human breast milk, how it affects milk production, or if it has any effects on a breastfed infant. Because many drugs are excreted in human milk, caution is advised. Healthcare providers typically consider the developmental and health benefits of breastfeeding alongside the mother's clinical need for the medication and any potential adverse effects on the infant from the drug or the underlying maternal condition.

Q: What is the FDA approval status of olezarsen?

FDA Approval and Indication The U.S. Food and Drug Administration (FDA) approved olezarsen in December 2024. It is indicated for use in adults with familial chylomicronemia syndrome (FCS) to help lower triglyceride levels. FCS is a rare genetic condition that prevents the body from breaking down certain fats, often leading to very high triglyceride levels and a risk of acute pancreatitis. Regulatory Designations Olezarsen received several special designations from the FDA during its development process to address the unmet medical needs of patients with FCS: Orphan Drug Designation: This status is given to drugs intended for the treatment of rare diseases. Fast Track Designation: This process is designed to facilitate the development and speed up the review of drugs that treat serious conditions. Breakthrough Therapy Designation: This is granted to drugs that may demonstrate substantial improvement over existing therapies for serious conditions. Safety and Monitoring There are no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) programs currently required for this medication. Regulatory approval was based on clinical data showing a significant reduction in triglyceride levels compared to a placebo. Healthcare providers typically monitor for potential side effects, such as injection site reactions or changes in laboratory tests, as part of standard clinical practice.

Question 1

What is olezarsen?

Accepted Answer

Olezarsen is an antisense oligonucleotide that targets the production of specific proteins involved in fat metabolism. It is designed to assist the body in regulating triglyceride levels within the blood.

The medication works by interfering with the genetic instructions for apolipoprotein C-III. By reducing the amount of this protein, the body can more efficiently process and clear fats from the circulation.

Question 2

What is olezarsen used for?

Accepted Answer

olezarsen is used to treat investigational treatment for severe hypertriglyceridemia (not FDA-approved).

Question 3

How does olezarsen work?

Accepted Answer

Mechanism of Action

Olezarsen is a type of medication known as an antisense oligonucleotide. It works by targeting and blocking the genetic instructions (mRNA) that the body uses to produce a protein called apolipoprotein C-III (apoC-III).

Role of apoC-III

The apoC-III protein is primarily made in the liver and plays a key role in regulating fat levels in the blood. Under normal conditions, this protein inhibits the enzymes responsible for breaking down triglycerides and prevents the liver from clearing certain fat particles from the bloodstream.

How Olezarsen Lowers Triglycerides

By reducing the amount of apoC-III protein available, olezarsen helps the body manage fats more effectively. This results in:

Increased fat breakdown: Lower levels of apoC-III allow enzymes to more efficiently break down triglycerides.
Improved clearance: The body can more easily remove triglyceride-rich particles from the blood.

This mechanism helps significantly lower triglyceride levels in adults with familial chylomicronemia syndrome (FCS), a condition where the body cannot properly break down fats.

Question 4

What are the active ingredients in olezarsen?

Accepted Answer

The active ingredient in olezarsen is olezarsen.

Question 5

What are the side effects of olezarsen?

Accepted Answer

Common side effects of olezarsen may include:

injection site reactions
fatigue
headache

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is olezarsen?

Accepted Answer

olezarsen belongs to the antisense oligonucleotide drug class.

Question 7

What is the dosage of olezarsen and how do I take it?

Accepted Answer

How to Use

Olezarsen is administered as an injection under the skin (subcutaneously). It is typically used once monthly. A healthcare provider will provide instructions on how to properly inject the medication if you or a caregiver will be performing the injections at home.

Administration and Sites

The injection can be given in the abdomen, the front of the thighs, or the outer area of the upper arms. It is important to rotate the injection site each time you use the medication. Avoid injecting into areas where the skin is tender, bruised, red, or scarred.

Preparation

The medication should be taken out of the refrigerator and allowed to reach room temperature before use. Do not shake the syringe. Before injecting, check the liquid to ensure it is clear and colorless to slightly yellow. If the liquid is cloudy or contains visible particles, do not use it.

Missed Dose

If you miss a dose, take it as soon as possible. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not use extra medication to make up for a missed dose.

Question 8

Is olezarsen safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate or well-controlled studies on the use of olezarsen in pregnant women. While animal studies did not show evidence of harm to the fetus at doses significantly higher than the recommended human dose, it is not known if the drug will cause harm to a human pregnancy.

If you are pregnant or planning to become pregnant, talk to your healthcare provider about the potential risks and benefits of continuing or starting this medication.

Breastfeeding

It is currently unknown if olezarsen passes into human breast milk, how it affects milk production, or if it has any effects on a breastfed infant. Because many drugs are excreted in human milk, caution is advised.

Healthcare providers typically consider the developmental and health benefits of breastfeeding alongside the mother's clinical need for the medication and any potential adverse effects on the infant from the drug or the underlying maternal condition.

Question 9

What forms and strengths does olezarsen come in?

Accepted Answer

Olezarsen is supplied as a sterile solution for injection. It is administered subcutaneously, which means it is injected into the fatty tissue just under the skin.

This medication is available in the following form:

Subcutaneous Injection: Provided in a single-dose prefilled syringe.

Question 10

What is the FDA approval status of olezarsen?

Accepted Answer

FDA Approval and Indication

The U.S. Food and Drug Administration (FDA) approved olezarsen in December 2024. It is indicated for use in adults with familial chylomicronemia syndrome (FCS) to help lower triglyceride levels. FCS is a rare genetic condition that prevents the body from breaking down certain fats, often leading to very high triglyceride levels and a risk of acute pancreatitis.

Regulatory Designations

Olezarsen received several special designations from the FDA during its development process to address the unmet medical needs of patients with FCS:

Orphan Drug Designation: This status is given to drugs intended for the treatment of rare diseases.
Fast Track Designation: This process is designed to facilitate the development and speed up the review of drugs that treat serious conditions.
Breakthrough Therapy Designation: This is granted to drugs that may demonstrate substantial improvement over existing therapies for serious conditions.

Safety and Monitoring

There are no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) programs currently required for this medication. Regulatory approval was based on clinical data showing a significant reduction in triglyceride levels compared to a placebo. Healthcare providers typically monitor for potential side effects, such as injection site reactions or changes in laboratory tests, as part of standard clinical practice.

Question 11

What should I know about olezarsen and cost?

Accepted Answer

Insurance and Out-of-Pocket Costs

The price of olezarsen is determined by your health insurance plan's formulary and tier placement. As a specialty medication, it may require prior authorization from your insurance company before coverage is approved. Patients may be responsible for a copayment or coinsurance, which is a percentage of the drug's total cost.

Specialty Pharmacy Access

Olezarsen is typically distributed through specialty pharmacies rather than standard retail pharmacies. These pharmacies specialize in handling medications that require specific storage conditions or close monitoring. The cost may vary between different specialty pharmacy providers.

Financial Support Options

Manufacturers of specialty drugs often provide resources to help patients afford treatment. These may include:

Copay Savings Programs: These can lower out-of-pocket costs for eligible patients with private or commercial insurance.
Patient Assistance Programs: These programs may provide the medication at no cost or a reduced cost for patients who meet certain financial criteria and lack adequate insurance coverage.

To find the most accurate cost, check with your insurance provider or contact the manufacturer's support services.

olezarsen

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for olezarsen

Hospitals.net Disclosure